PUBLIC CONSULTATION NOW OPEN ** Draft International Consensus Guideline on Anticancer Drug Dosing in Kidney Dysfunction (ADDIKD) **

The ADDIKD draft guideline is open for public consultation until midnight (AEST) 31st May 2022.  The BOPA Committee would appreciate your input with this process.

The Draft Guideline can be accessed here: https://www.eviq.org.au/getmedia/7f42c39e-2100-40aa-b358-575c485ce3da/Draft-ADDIKD-Guideline-V7.aspx

If you have any questions, please contact Geeta Sandhu on [email protected] submit you feedback please scan the QR code below or see the consultation information here: https://www.bopa.org.uk/resources/addikd-flyer-final/

Latest News

By BOPA Executive Committee on 14th May 2025

BOPA Fellowship Nominations are NOW OPEN!

We are pleased to announce that BOPA Fellowship Nominations have now opened for 2025.  There is a clear nomination and selection process including specific criteria for assessing the nominated individuals.…

Read article
By BOPA Committee on 13th May 2025

#BOPA2025 at ICC Belfast – Draft Agenda now available

The 28th British Oncology Pharmacy Association (BOPA) Annual Conference, 3-5 October 2025, ICC Belfast The Draft Agenda is available to view here: https://www.bopa.org.uk/resources/the-28th-bopa-annual-conference-2025-draft-agenda/ The conference will include an exciting variety…

Read article
By BOPA Research Committee on 10th May 2025

Request for Support in Dissertation Research on Genetic Competencies for Pharmacist working in cancer

Dear Members, The BOPA research committee would like to invite members to participate in a research project on Genetic core competencies for clinical pharmacists in the cancer setting: a literature…

Read article
By BOPA Education & Training Subcommittee on 7th May 2025

The BOPA Advanced Pharmacist Training Day June 2025

Overview – This study day is intended to provide an overview of the knowledge, skills, experiences and behaviours required to practice at an advanced level in Cancer Care. The study day…

Read article